Edition:
India

Akcea Therapeutics Inc QTRLY Net Loss Per Share Of Common Stock Was $0.72


Tuesday, 7 Aug 2018 

Aug 6 (Reuters) - Akcea Therapeutics Inc ::AKCEA REPORTS FINANCIAL RESULTS AND HIGHLIGHTS FOR SECOND QUARTER 2018.AKCEA THERAPEUTICS INC QTRLY RESEARCH AND DEVELOPMENT REVENUE $18.3 MILLION VERSUS $5.7 MILLION.AKCEA THERAPEUTICS INC QTRLY NET LOSS PER SHARE OF COMMON STOCK [OWNED BY IONIS] WAS $0.72.AKCEA THERAPEUTICS INC QTRLY NET LOSS PER SHARE OF COMMON STOCK [OWNED BY OTHERS] WAS $0.85.